ABIONYX Pharma vs Spark Therapeutics
ABIONYX Pharma vs Spark Therapeutics, compared side by side on 18 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: ABIONYX Pharma is on 44/100 and Spark Therapeutics on 58/100.
Where each one leads
ABIONYX Pharma
- funding raised: $225M against $82.8M
Spark Therapeutics
- our overall score: 58/100 against 44/100
- domain rating: 80/100 against 25/100
At a glance
| Measure | ABIONYX Pharma | Spark Therapeutics |
|---|---|---|
| What it is | Biopharmaceutical company developing innovative therapies for sepsis and intensive care. | A biotechnology company developing gene therapy treatments for rare, debilitating genetic diseases. |
| Category | Biotechnology, Pharmaceuticals, Healthcare, Biotech | Biotechnology, Gene Therapy, Healthcare, Pharmaceuticals |
| Sells toBusiness model | B2B | B2B |
| Offering | Services | Services |
| Founded | 2015 | 2013 |
| Headquarters | Toulouse, France | Philadelphia, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | ABIONYX Pharma | Spark Therapeutics |
|---|---|---|
| Total funding | $225M | $82.8M |
| Latest round | Capital Increase | Series B |
| Valuation | $1.1B | Not published |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | ABIONYX Pharma | Spark Therapeutics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 44/100 | 58/100 |
| Traction | 40/100 | 40/100 |
| Team | 20/100 | 90/100 |
| Search visibility | 5/100 | 13/100 |
| Quality | 58/100 | 65/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (43/100) | F (39/100) |
| Domain ratingLink authority, 0-100 | 25/100 | 80/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | ABIONYX Pharma | Spark Therapeutics |
|---|---|---|
| Hosting | Self Managed | Not detected |
| CDN | Not detected | Cloudflare |
| Frameworks | Jquery | Jquery |
| Analytics | Google Analytics 4 | Google Tag Manager |
What users say
| Measure | ABIONYX Pharma | Spark Therapeutics |
|---|---|---|
| Reddit sentimentThreads we track | Not published | 1 positive, 0 negative across 3 threads |
“The Daily Biotech Pulse: Pfizer Strikes $5.29B COVID Pill Supply Deal With US, Roche's Spark Therapeutics Reports Positive Gene Therapy Readout, EDAP Earnings.”r/conspiracy
ABIONYX Pharma vs Spark Therapeutics: common questions
Which is better, ABIONYX Pharma or Spark Therapeutics?
On our 0-100 score Spark Therapeutics rates higher (58/100 against 44/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 18 data points above: read the rows that match what you are buying for.
How do ABIONYX Pharma and Spark Therapeutics compare on the numbers?
ABIONYX Pharma leads on funding raised ($225M against $82.8M). Spark Therapeutics leads on our overall score (58/100 against 44/100), domain rating (80/100 against 25/100).
What do real users say about ABIONYX Pharma and Spark Therapeutics?
Spark Therapeutics: 1 positive and 0 negative mentions across 3 Reddit threads we track, mostly in r/conspiracy.
Read the full ABIONYX Pharma review and pricing or the Spark Therapeutics review and pricing. You can also browse other ABIONYX Pharma alternatives we track.